GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Biotage AB (OTCPK:BITGF) » Definitions » Non Operating Income

Biotage AB (Biotage AB) Non Operating Income : $0.0 Mil (TTM As of Mar. 2024)


View and export this data going back to 2010. Start your Free Trial

What is Biotage AB Non Operating Income?

Non Operating Income is income or expense that comes from miscellaneous sources. Biotage AB's Non Operating Income for the three months ended in Mar. 2024 was $0.0 Mil. Its Non Operating Income for the trailing twelve months (TTM) ended in Mar. 2024 was $0.0 Mil.


Biotage AB Non Operating Income Historical Data

The historical data trend for Biotage AB's Non Operating Income can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Biotage AB Non Operating Income Chart

Biotage AB Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Non Operating Income
Get a 7-Day Free Trial Premium Member Only Premium Member Only - - - - -

Biotage AB Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Non Operating Income Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

Biotage AB Non Operating Income Calculation

Non Operating Income is income or expense that comes from miscellaneous sources.

Non Operating Income for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was $0.0 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Biotage AB Non Operating Income Related Terms

Thank you for viewing the detailed overview of Biotage AB's Non Operating Income provided by GuruFocus.com. Please click on the following links to see related term pages.


Biotage AB (Biotage AB) Business Description

Traded in Other Exchanges
Address
Vimpelgatan 5, Box 8, Uppsala, SWE, 751 03
Biotage AB provides separation technology and solutions for analytical and organic chemistry from research to commercial analytical laboratories and industrial applications. Its customers span a broad range of market segments including pharmaceutical, biotech, diagnostic, contract research, and contract manufacturers as well as clinical, forensic, and academic laboratories in addition to organizations focused on food safety, clean water, and environmental sustainability. It serves three geographic markets: The Americas, APAC (Asia-Pacific,) and EMEA (Europe, Middle East & Africa). The company's product areas include Small Molecules & Synthetic Therapeutics, Biologics & Advanced Therapeutics, Scale-Up, Diagnostics, Analytical Testing, and Water & Environmental Testing.

Biotage AB (Biotage AB) Headlines

From GuruFocus

Biotage AB (publ) appoints new CFO

By PRNewswire PRNewswire 07-01-2021

Biotage AB (publ) Year-end report January - December 2021

By PRNewswire PRNewswire 02-11-2022

Biotage - Change in number of shares and votes

By PRNewswire PRNewswire 10-29-2021

Notice of Annual General Meeting in Biotage AB (publ)

By PRNewswire PRNewswire 04-28-2020

Biotage AB (publ) publishes new Financial Goals

By PRNewswire PRNewswire 03-14-2022

Biotage AB (publ) Interim report January - September 2021

By PRNewswire PRNewswire 10-28-2021

Biotage AB (publ) Interim report January - June 2021

By PRNewswire PRNewswire 07-16-2021

Issue and re-purchase of class C shares for incentive program

By PRNewswire PRNewswire 11-30-2021